Asterios Deligiannis | Medicine | Best Innovation Award

Best Innovation Award

Asterios Deligiannis

Researcher Information
Affiliation Aristotle University of Thessaloniki
Country Greece
Scopus ID 7003501457
Documents 127
Citations 5,944
h-index 28
Subject Area Chemistry
Event Scientific World Research Awards
ORCID 0000-0001-7765-1897

Asterios Deligiannis is an academic affiliated with Aristotle University of Thessaloniki, Greece. His scholarly record demonstrates extensive research productivity, interdisciplinary collaboration, and sustained scientific contribution. According to available research metrics, he has produced 127 indexed publications, received 5,944 citations, and achieved an h-index of 28, reflecting broad academic visibility and influence across multiple research domains.[1][2]

Abstract

This article presents an overview of the academic achievements of Asterios Deligiannis. His research portfolio encompasses a substantial body of scholarly work, international collaborations, and contributions to scientific knowledge. Available publication metrics indicate 127 indexed documents, 5,944 citations, and an h-index of 28, reflecting sustained research productivity and scholarly influence.[1] His academic activities include participation in international research initiatives, professional organizations, and peer-reviewed publications. These accomplishments demonstrate innovation, research leadership, and measurable scientific impact, supporting consideration for recognition through the Best Innovation Award within an international academic framework.[2]

Keywords

Innovation, Chemistry, Scientific Research, Academic Impact, Research Excellence, Scholarly Contributions.

Introduction

Research innovation is commonly assessed through scientific productivity, influence, and contributions to knowledge development. Academic recognition programs frequently consider publication records, citation performance, and interdisciplinary engagement when evaluating researchers for distinguished awards.[1]

Research Profile

Deligiannis is affiliated with Aristotle University of Thessaloniki and maintains an active ORCID record. His professional activities include academic leadership, international memberships, and participation in collaborative research programs.[2]

Research Contributions

His scholarly contributions span cardiovascular health, exercise-related investigations, rehabilitation studies, and interdisciplinary scientific research. Numerous peer-reviewed publications demonstrate long-term engagement in advancing evidence-based knowledge and innovation.[3]

Publications

The researcher has authored 127 indexed publications and contributed to a broad collection of scientific articles published in international journals. His publication record reflects sustained scholarly activity and extensive collaboration across research communities.[1]

Research Impact

Research influence is demonstrated through 5,944 citations and an h-index of 28. These indicators suggest significant academic visibility and continuing relevance of his publications within scientific literature and research networks.[1]

Award Suitability

The combination of research productivity, scholarly impact, international engagement, and documented scientific contributions supports consideration for the Best Innovation Award. His profile reflects characteristics commonly associated with academic distinction and innovation-oriented recognition.[1]

Conclusion

Asterios Deligiannis has established a substantial academic record characterized by impactful publications, collaborative research activities, and measurable scholarly influence. These achievements provide a strong foundation for recognition within international research award programs.

References

  1. Elsevier. (n.d.). Scopus Author Details: Asterios Deligiannis, Author ID 7003501457. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=7003501457

  2. ORCID. (2026). Asterios Deligiannis ORCID Record.

    https://orcid.org/0000-0001-7765-1897

  3. Deligiannis, A., et al. (2025). Investigating the Role of Exercise in Improving Bone Health Among Elderly Women with Osteopenia.

    https://doi.org/10.3390/jfmk10040451

  4. Deligiannis, A., et al. (2025). Advanced Stress Echocardiography with Cardiopulmonary Exercise Testing After Myocardial Infarction.

    https://doi.org/10.3390/jfmk10040393

  5. Scientific World Research Awards. (n.d.). Official Award Information Portal.

    https://scientificworld.net/

Yoshiya Tanaka | Medicine | Innovative Research Award

Innovative Research Award

Yoshiya Tanaka

Yoshiya Tanaka
Affiliation Hospital of University of Occupational and Environmental Health
Country Japan
Scopus ID 56328279400
Documents 1,326
Citations 50,831
h-index 99
Subject Area Medicine
Event Scientific World Research Awards

Yoshiya Tanaka, Hospital of University of Occupational and Environmental Health, Japan, is recognized for substantial contributions to rheumatology, immunology, and autoimmune disease research. His scholarly output, clinical investigations, and leadership in international collaborations have supported advancements in evidence-based medical practice and therapeutic development.[1]

Abstract

The Innovative Research Award recognizes researchers whose work demonstrates sustained scientific excellence and measurable impact. Yoshiya Tanaka has contributed extensively to rheumatology and clinical immunology through studies on autoimmune diseases, inflammatory mechanisms, biologic therapies, and targeted treatments. His research has informed clinical guidelines, improved disease classification systems, and supported the development of therapeutic strategies for conditions such as systemic lupus erythematosus, rheumatoid arthritis, and IgG4-related disease. With a substantial publication record and broad international collaboration, his work has influenced both academic research and patient care, reflecting the objectives of the Scientific World Research Awards.[1][2]

Keywords

Rheumatology, Clinical Immunology, Autoimmune Diseases, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Biologic Therapy, Translational Medicine.

Introduction

Modern rheumatology depends on interdisciplinary research linking immunology, molecular biology, and clinical practice. Yoshiya Tanaka has participated in investigations that enhanced understanding of inflammatory pathways and treatment approaches for immune-mediated diseases.[3]

Research Profile

As Professor and Chairman in rheumatology and clinical immunology, Tanaka has developed a research portfolio focused on disease mechanisms, therapeutic innovation, and clinical trial leadership. His scholarly record reflects long-term engagement with translational medicine and global collaboration.[1]

Research Contributions

Key contributions include studies supporting lupus classification criteria, IgG4-related disease frameworks, Janus kinase inhibitor development, and biologic treatment evaluation. These efforts have contributed to improved disease assessment and therapeutic decision-making.[2][4]

Publications

  • 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus.
  • Trial of Anifrolumab in Active Systemic Lupus Erythematosus.
  • Janus Kinase-Targeting Therapies in Rheumatology.

Research Impact

The researcher’s publications have received extensive citations, demonstrating influence across clinical medicine and immunology. Findings from collaborative studies have informed guidelines, therapeutic development, and evidence-based healthcare practices internationally.[1][5]

Award Suitability

The breadth of scientific output, citation performance, clinical relevance, and leadership in collaborative research aligns with the objectives of the Innovative Research Award. His contributions demonstrate sustained scholarly influence and practical significance in medicine.

Conclusion

Yoshiya Tanaka’s career reflects a consistent commitment to advancing knowledge in rheumatology and autoimmune disease research. His achievements support recognition within international scientific award programs and academic communities.

References

  1. Elsevier. (n.d.). Scopus author details: Yoshiya Tanaka, Author ID 56328279400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56328279400
  2. Aringer, M., et al. (2019). 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus.
    DOI: https://doi.org/10.1002/art.40930
  3. Tanaka, Y., Adams, D.H., & Shaw, S. (1993). T-cell Adhesion Induced by Proteoglycan-Immobilized Cytokine MIP-1β.
    DOI: https://doi.org/10.1038/361079a0
  4. Tanaka, Y., Luo, Y., O’Shea, J.J., & Nakayamada, S. (2022). Janus Kinase-Targeting Therapies in Rheumatology.
    DOI: https://doi.org/10.1038/s41584-021-00726-8
  5. Google Scholar. (2026). Yoshiya Tanaka Citation Profile.
    https://scholar.google.com/citations?user=t_hAg7QAAAAJ&hl=en

Charles Dariane | Medicine | Research Excellence Award

Assist. Prof. Dr. Charles Dariane | Medicine | Research Excellence Award

MD PhD | European Hospital Georges Pompidou | France

Assist. Prof. Dr. Charles Dariane is a leading researcher in urologic oncology, focusing on prostate and renal cancer, advanced imaging, and robotic-assisted surgery. His research skills include clinical trials, surgical innovation, and multidisciplinary collaboration. He has contributed to international cancer guidelines and impactful publications. His Scopus metrics include 1,429 citations, 155 documents, and an h-index of 19. His work enhances precision medicine and improves outcomes in modern urological cancer care.

 

Citation Metrics (Scopus)

1429
1000
700
300
0

Citations

1429

Documents

155

h-index

19

Citations

Documents

h-index

View Scopus Profile

Featured Publications

 

Lina Posada Calderon | Medicine | Research Excellence Award

Dr. Lina Posada Calderon | Medicine | Research Excellence Award

Resident | New York Presbyterian | United States

Dr. Lina Posada Calderon is an accomplished biomedical researcher at Weill Cornell Medicine, New York, specializing in translational and molecular cancer research. Her work focuses on the clinical and molecular characterization of cancers, precision oncology, biomarker discovery, and genetic drivers of tumor progression, with particular emphasis on KRAS-mutated malignancies. She has strong expertise in molecular biology, cancer genomics, clinical data analysis, interdisciplinary research, and high-impact scientific publishing. Her research bridges laboratory discoveries with patient-centered clinical outcomes. Dr. Posada Calderon has published 12 Scopus-indexed documents, receiving 61 citations, and holds an h-index of 5, reflecting her growing scholarly impact and emerging leadership in precision cancer research.

 

Citation Metrics (Scopus)

61
45
30
15
0

Citations

61

Documents

12

h-index

5

Citations

Documents

h-index

View Scopus Profile
View Google Scholar

Featured Publications

 

Philipp Kanske | Medicine | Research Excellence Award

Prof. Dr. Philipp Kanske | Medicine | Research Excellence Award

Professor | TUD Dresden University of Technology | Germany

Prof. Dr. Philipp Kanske is an internationally recognized expert in cognitive and affective neuroscience whose work bridges psychology, social cognition, neuroimaging, and mental health research. His research centers on empathy, compassion, emotion regulation, personality functioning, and the neurobiological mechanisms that shape human social behavior across the lifespan. He investigates how individuals perceive and respond to others’ emotions, how empathic stress is transmitted within families, and how interventions such as meditation and compassion training can induce functional neural plasticity and improve emotional well-being, particularly in older adults. His interests extend to personality organization in both clinical and non-clinical populations, disease progression in bipolar disorder, white-matter microstructure, attachment dynamics in couples, value integration for self and others, and ritual-based methods for strengthening human–nature connectedness in the context of sustainability transformations. Prof. Kanske is skilled in a wide range of methodologies including experimental psychology, behavioral analysis, longitudinal study design, cognitive testing, psychoneuroendocrinology, structural and functional MRI, and advanced statistical modeling. His contributions to research transparency and reproducibility are reflected in his leadership in developing the PECANS methodological framework for cognitive and neuropsychological studies. Throughout his career, he has received multiple awards and honors (as listed in Scopus’s “Awarded Grants” section), recognizing his innovative contributions to social neuroscience, aging research, and clinical psychology. According to Scopus Preview, he has 7,136 citations, 163 documents, and an impressive h-index of 43, underscoring his global scientific influence and sustained scholarly productivity. Overall, Prof. Dr. Philipp Kanske’s work provides significant insights into how emotional, neural, and relational processes shape human behavior, offering important implications for mental health, interpersonal functioning, and societal well-being, and solidifying his role as a leading figure in modern neuroscience and psychology.

ProfilesScopus | ORCID | Google Scholar

Featured Publications

  1. Kanske, P., Heissler, J., Schönfelder, S., Bongers, A., & Wessa, M. (2011). How to regulate emotion? Neural networks for reappraisal and distraction. Cerebral Cortex, 21(6), 1379–138.
    Citations: 698

  2. Schurz, M., Radua, J., Tholen, M. G., Maliske, L., Margulies, D. S., Mars, R. B., … Kanske, P. (2021). Toward a hierarchical model of social cognition: A neuroimaging meta-analysis and integrative review of empathy and theory of mind. Psychological Bulletin, 147(3), 293–. Citations: 648

  3. Kanske, P., & Kotz, S. A. (2007). Concreteness in emotional words: ERP evidence from a hemifield study. Brain Research, 1148, 138–148. Citations: 630

  4. Preckel, K., Kanske, P., & Singer, T. (2018). On the interaction of social affect and cognition: Empathy, compassion and theory of mind. Current Opinion in Behavioral Sciences, 19, 1–6.
    Citations: 554

  5. Moshontz, H., Campbell, L., Ebersole, C. R., IJzerman, H., Urry, H. L., Forscher, P. S., … Kanske, P. (2018). The Psychological Science Accelerator: Advancing psychology through a distributed collaborative network. Advances in Methods and Practices in Psychological Science, 1(4), 501–515. Citations: 499

Prof. Dr. Philipp Kanske’s work advances global scientific understanding of empathy, compassion, and emotion regulation by uncovering the neural and psychological mechanisms that drive healthy social functioning. His research enables evidence-based mental-health interventions, strengthens human well-being across communities, and supports interdisciplinary innovation in neuroscience, clinical psychology, aging research, and societal resilience.

 

Yigit Akin | Medicine | Best Researcher Award

Prof. Dr. Yigit Akin | Medicine | Best Researcher Award

Yigit Akin | Izmir Kâtip Celebi University School of Medicine | Turkey

Professor Yigit Akin is a distinguished urologist and academic leader specializing in uro-oncology, robotic surgery, and minimally invasive laparoscopy. He earned his M.D. from Ege University Faculty of Medicine in 2004 and completed advanced training in robotics, laparoscopy, and uro-oncology at Klinikum Heilbronn, Germany, between 2013 and 2014. Currently, he serves as Head of Urology at Izmir Katip Celebi University, Turkey, leading one of the country’s premier uro-oncology centers. With over 210 peer-reviewed publications, 14 book chapters, and editorial board memberships in international journals, his contributions are well recognized in PubMed and IEEE-indexed forums. He has directed multiple multidisciplinary and international research projects, notably pioneering the extraperitoneal laparoscopic radical prostatectomy using 3 trocars (#3trocarsELRP), with more than 1300 successful procedures. A global mentor in laparoscopic surgery, Prof. Akin has conducted live surgical workshops and training in over 10 countries, while also supervising international clinical fellows. His leadership extends to community-based medical training, editorial contributions, and professional memberships in leading medical and surgical associations. Prof. Akin is strongly positioned to lead next-generation cancer genetics and surgical innovation research. His expertise in developing novel laparoscopic techniques, combined with mentorship of global fellows, demonstrates the potential to advance robotic uro-oncology surgery, elevate Q1 journal contributions, and strengthen international collaborations that will shape the future of minimally invasive urology worldwide.

Profile: ORCID 

Featured Publications

orulmaz, E. M., Dönmez, K., Görgel, S. N., & Akin, Y. (2025). Penil fraktür nedeniyle opere edilen hastaların klinik sonuçları ve komplikasyonlarla ilişkili faktörler: 10 yıllık sonuçlarımız. Androloji Bülteni.

Tekinaslan, H., Görgel, S. N., & Akin, Y. (2025). Malekot kateter kırığına bağlı retroperitoneal yabancı cisim: Nadir bir olgu sunumu. Endouroloji Bülteni.

Dama, M., Yorulmaz, E. M., Özcan, S., Köse, O., Görgel, S. N., & Akin, Y. (2025). AISI, SIRI, and MLR in predicting surgical outcomes after radical cystectomy: Revisiting inflammatory risk markers. Medicina, 61(10), 1756.

Dama, M., Yorulmaz, E. M., Özcan, S., Köse, O., Görgel, S. N., & Akin, Y. (2025). Optimising imaging strategies in suspected urolithiasis: Effects on diagnostic and therapeutic timelines. Harran Üniversitesi Tıp Fakültesi Dergisi.

Özcan, S., Dama, M., Yorulmaz, E. M., Köse, O., Görgel, S. N., & Akin, Y. (2025). Holmium laser enucleation of the prostate and postoperative dysuria: A 20-year bibliometric perspective. Trends in Surgical Sciences.